An imbalance in plasma prostanoids in patients with Raynaud's phenomenon and pulmonary vasospasm

European Respiratory Journal

Volumn 13, Issue 1, 1999, Pages 137-144

  Sakamoto, K ^a   Houya, I ^a   Inoue, K ^a   Tanaka, M ^a   Suzuki, T ^a   Sakamoto, Y ^a   Matsuo, H ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Prostaglandin I2; Pulmonary vasospasm; Raynaud's phenomenon; Thromboxane A2

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ENDOTHELIN 1; PROSTACYCLIN; PROSTANOID; THROMBOXANE B2; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HUMAN; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; MALE; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN SYNTHESIS; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS; VASOSPASM;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; AGED; COLD; ENDOTHELIN-1; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY VEINS; RAYNAUD DISEASE; RESPIRATORY FUNCTION TESTS; SPASM; THROMBOXANE B2; VASCULAR DISEASES;

EID: 0032995662     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.99.13113799     Document Type: Article

References (43)

1. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodman GP, Medsger TA Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515-524.
2. Graziano FM, Friedman LC, Grossman J. Pulmonary hypertension in a patient with mixed connective tissue disease: clinical and pathological findings, and review of literature. Clin Exp Rheumatol 1983; 1: 251-255.
3. Cannon P, Hasson M, Case DP, Casarella WJ, Somners SC, LeRoy EC. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine 1974; 53: 146.
4. Eliss WW, Baer AN, Robertson RM, Pincus T, Kronengerg MW. Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis. Am J Med 1986; 80: 385-392.
5. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107: 216-223.
6. Furst DE, Davis JA, Clements PJ, Chopra SK, Theofilopoulos AN, Chia D. Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis. Arthritis Rheum 1981; 24: 1403-1408.
7. Barr WG, Fahey PJ. Reduction of pulmonary capillary blood volume following cold exposure in patients with Raynaud's phenomenon. Chest 1988; 94: 1195-1199.
8. Shuck JW, Oetgen WJ, Tesar JT. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis. Am J Med 1985; 78: 221-227.
9. 2 biosynthesis in patients with angina pectoris. Am Heart J 1986; 112: 472-478.
10. Zsmora MR, O'Brien RF, Rutherford RB, Weil JV. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 1990; 336: 1144-1147.
11. Christman BW, McPherson CD, Newman JH, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992; 327: 70-75.
12. Porter JF, Kingsland LC III, Lindberg DAB, et al. The AI/RHEUM knowledge-based computer consultant system in rheumatology. Performance in the diagnosis of 59 connective tissue disease patients from Japan. Arthritis Rheum 1988; 31: 219-226.
13. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
14. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique. Am J Respir Crit Care Med 1995; 152: 2185-2198.
15. Baldwin E deF, Cournand A, Richards DW Jr. Pulmonary insufficiency, physiological classification, clinical methods of analysis, standard values in normal subjects. Medicine 1948; 27: 243-278.
16. Nishida O, Kambe M, Sewake N, et al. Pulmonary function in healthy subjects and its prediction, 5. Pulmonary diffusing capacity in adults. Jpn J Clin Pathol 1976; 24: 941-947 (in Japanese).
17. Yang SC, Yang SP, Lin PJ. Prediction equations for single-breath carbon monoxide diffusing capacity from a Chinese population. Am Rev Respir Dis 1993; 147: 599-606.
18. Crapo RO, Morris AH. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 123: 185-189.
19. Powell WS. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 1980; 20: 947-957.
20. Kobayashi Y, Sakamoto Y, Shibasaki M, Kimura I, Matsuo H. Human alveolar macrophages synthesize endothelins by thrombin. J Immunol 1997; 158: 5442-5447.
21. Fiorentini C, Barbier P, Galli C. et al. Pulmonary vascular overreactivity in systemic hypertension. A pathophysiological link between the greater and the lesser circulation. Hypertension 1985; 7: 995-1002.
22. Kahaleh B, Matucci-Cerinic M. Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone. Arthritis Rheum 1995; 38: 1-4.
23. Kahaleh MB, Osborn I, LeRoy EC. Increased factor VIII/ von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med 1981; 94: 482-484.
24. Jubelirer SJ. Primary pulmonary hypertension. Its association with microangiopathic hemolytic anaemia and thrombocytopenia. Arch Intern Med 1991; 151: 1221-1223.
25. Hutton RA, Mikhailidis DP, Bernstein RM, Jeremy JY, Hughes GRV, Dandona P. Assessment of platelet function in patients with Raynaud's syndrome. J Clin Pathol 1984; 37: 182-187.
26. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992; 19; 753-757.
27. Marsen TA, Simonson MS, Dunn MJ. Thrombin induces the preproendothelin-1 gene in endothelial cells by a protein tyrosine kinase-linked mechanism. Circ Res 1995; 76: 987-995.
28. White MM, Zamudio S, Stevens T, et al. Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms. Endocr Rev 1995; 16: 739-751.
29. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease-ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325: 756-762.
30. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786-791.
31. Kawano H, Motoyama T, Kugiyama K, et al. Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. J Am Coll Cardiol 1997; 30: 914-919.
32. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 1995; 360: 291-293.
33. Henriksson P, Stege R, Gréen K. Profound decrease of in vivo formation of thromboxane during estrogen therapy. Eur J Clin Invest 1996; 26: 1186-1188.
34. Mikkola T, Turunen P, Avela K, Orpana A. Viinikka L, Ylikorkala O. 17β-Estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab 1995; 80: 1832-1836.
35. Fogelberg M, Vesterqvist O, Diczfalusy U, Henriksson P. Experimental atherosclerosis: effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation. Ear J Clin Invest 1990; 20: 105-110.
36. 2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol 1994; 266: C975-C980.
37. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991; 261: R1022-R1027.
38. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophy Res Commun 1994; 205: 905-910.
39. Jiang CW, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol 1992; 211: 163-167.
40. Farhat MY, Ramwell PW. Estradiol potentiates the vasopressor response of the isolated perfused rat lung to the thromboxane mimic U-46619. J Pharmacol Exp Ther 1992; 261: 686-691.
41. Terregino CA, Seibold JR. Influence of the menstrual cycle on Raynaud's phenomenon and on cold tolerance in normal women. Angiology 1985; 36: 88-95.
42. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-301.
43. Wigley PM, Seibold JR, Wise RA, McCloskey DA, Dole WP. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol 1992; 19: 1407-1414.